CULLGEN
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies. The company's services use protein degradation technology that focuses on selective degradation of disease-causing proteins, novel treatment for cancer, inflammatory and autoimmune diseases, including targets previously considered undruggable, enabling scientists with new means to develop novel therapeutic approaches for various diseases.
CULLGEN
Industry:
Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.cullgen.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
66 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Typekit Squarespace Squarespace Hosted
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
ARGOBIO
Argobio is a start-up studio for therapeutics aiming to nurture and launch biotech companies.
ArriVent Biopharma
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Avalyn Pharma
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Biosortia Microbiomics
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Cajal Neuroscience
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Cardior Pharmaceuticals
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
Catalent Pharma Solutions
Catalent provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies.
Dogma Therapeutics
Dogma is developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. https://www.dogmatherapeutics.com/
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Genomic Prediction
Genomic Prediction provides advanced genetic testing for IVF.
Glycologix
Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.
GlyTech
GlyTech is a responsibility of the company to protect personal information in its business activities.
Igyxos
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Levo Therapeutics
Levo Therapeutics is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Netherlands Translational Research Center B.V.
Netherlands Translational Research Center translates novel biological concepts on the treatment of diseases into small molecule drugs.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
PharmaTher
PharmaTher is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Science Exchange
Science Exchange, the R&D Services Management company, empowers research organizations to accelerate science and drive innovation success
Sentinel Oncology
Sentinel Oncology is a drug discovery company specialising in the delivery of candidate drugs to treat diseases.
SUN bioscience
SUN bioscience creates advanced cell culture platforms.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Vibliome
Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.
Vicarius Pharma
Vicarius Pharma was founded to provide research-driven pharmaceutical
XellSmart
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
Current Employees Featured
Founder
Investors List
Heights Capital Management
Heights Capital Management investment in Series B - Cullgen
South China Venture Capital
South China Venture Capital investment in Series B - Cullgen
MSA Capital
MSA Capital investment in Series B - Cullgen
Octagon Capital Partners
Octagon Capital Partners investment in Series B - Cullgen
3E Bioventures
3E Bioventures investment in Series B - Cullgen
Highlight Capital
Highlight Capital investment in Series A - Cullgen
Sequoia Capital China
Sequoia Capital China investment in Series A - Cullgen
GNI Group
GNI Group investment in Seed Round - Cullgen
Official Site Inspections
http://www.cullgen.com Semrush global rank: 5.68 M Semrush visits lastest month: 1.48 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Cullgen"
Cullgen - Crunchbase Company Profile & Funding
Cullgen is a drug discovery service intended to create new drugs for the treatment of diseases that currently lack effective therapies. The company's services use protein degradation technology that focuses on the selective degradation of …See details»
Corporate Controller — Cullgen
Cullgen is a privately held biopharmaceutical company dedicated to the development of first-in-class new chemical entities (NCEs) for the treatment of diseases lacking effective therapeutic …See details»
Cullgen
Nov 13, 2024 12730 High Bluff Drive, Suite 250. San Diego, CA 92130. [email protected]See details»
Cullgen Inc. - LinkedIn
Cullgen Inc., is a San Diego based biotechnology company developing small molecule therapeutics based on our proprietary targeted protein degradation (TPD) technology, uSMITE™.See details»
Cullgen Company Profile 2025: Valuation, Funding & Investors
When was Cullgen founded? Cullgen was founded in 2018. Where is Cullgen headquartered? Cullgen is headquartered in San Diego, CA. What is the size of Cullgen? Cullgen has 115 total …See details»
Cullgen - Funding, Financials, Valuation & Investors - Crunchbase
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies. Search Crunchbase. ... Which types of acquisition does …See details»
Cullgen - Contacts, Employees, Board Members, Advisors & Alumni
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies. ... Chrome Extension. Solutions. Products. Resources. …See details»
Cullgen Company Profile - Office Locations, Competitors ... - Craft
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders for the treatment of diseases lacking effective therapeutic approaches. The …See details»
Cullgen Inc. Company Overview, Contact Details & Competitors
May 8, 2023 Cullgen Inc. Biotechnology Research California, United States 51-200 Employees. Cullgen is a biopharmaceutical company that has developed protein degradation technology …See details»
About - Cullgen
12730 High Bluff Drive, Suite 250. San Diego, CA 92130. [email protected]See details»
Cullgen - Overview, News & Similar companies | ZoomInfo.com
Cullgen contact info: Phone number: (858) 284-0115 Website: www.cullgen.com What does Cullgen do? Founded in 2018 and headquartered in San Diego, California, Cullgen is a …See details»
Office Manager/ Administrative Assistant — Cullgen
Cullgen is a privately held biopharmaceutical company dedicated to the development of first-in-class new chemical entities (NCEs) for the treatment of diseases lacking effective therapeutic …See details»
Cullgen - Products, Competitors, Financials, Employees, …
Cullgen provides biopharmaceutical solutions focusing on developing protein degradation technology to treat cancer and other debilitating diseases. The company offers a platform …See details»
Astellas extends protein degrader drive with Cullgen deal
2 days ago Under the terms of the deal, Cullgen is in line for another $85 million payment if Astellas exercises an option on the lead programme once it is ready for clinical development. …See details»
Cullgen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cullgen, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 25 news, and 24 literature, Disease Domain:Nervous System ...See details»
Plumatrix to merge with Cullgen Inc. – Medthority
Nov 15, 2024 In 2023 Cullgen completed a Series C financing led by AstraZeneca-CICC Venture Capital Partnership, and also announced a strategic partnership with Astellas Pharma …See details»
Contact Us - Cullgen
12730 High Bluff Drive, Suite 250. San Diego, CA 92130. [email protected]See details»
Cullgen Entering Public Market with Pulmatrix Merger
Nov 27, 2024 Cullgen has had a steady uptick since its founding in 2018 by Jian Jin (on Cullgen’s board of directors) and Yue Xiong (the company’s Chief Scientific Officer). In 2023 …See details»
Astellas and Cullgen — Cullgen
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses, and to co-promote partnered products in the U.S. for the lead …See details»
News & Press Releases - Cullgen
December 10, 2019 Cullgen Inc., a biotechnology company developing small molecule therapeutics based on targeted protein degradation technology (commonly known as …See details»